UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

Progression of motor and nonmotor features of Parkinson's disease and their response to treatment

British journal of clinical pharmacology, 2012-08, Vol.74 (2), p.267-283

2012

Volltextzugriff (PDF)

SLCO1B1 rs4149032 Polymorphism Is Highly Prevalent in South Africans and Is Associated with Reduced Rifampin Concentrations: Dosing Implications

Antimicrobial Agents and Chemotherapy, 2011-09, Vol.55 (9), p.4122-4127

2011

Volltextzugriff (PDF)

The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis

European journal of clinical pharmacology, 2012-05, Vol.68 (5), p.689-695

2012

Volltextzugriff (PDF)

Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance

British journal of clinical pharmacology, 2007-01, Vol.63 (1), p.75-84

2007

Volltextzugriff (PDF)

Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease

British journal of clinical pharmacology, 2012-08, Vol.74 (2), p.284-295

2012

Volltextzugriff (PDF)

Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization

Clinical cancer research, 2014-02, Vol.20 (3), p.754-763

2014

Volltextzugriff (PDF)

The population pharmacokinetics of allopurinol and oxypurinol in patients with gout

European journal of clinical pharmacology, 2013-07, Vol.69 (7), p.1411-1421

2013

Volltextzugriff (PDF)

A combined pharmacokinetic model for the hypoxia-targeted prodrug PR-104A in humans, dogs, rats and mice predicts species differences in clearance and toxicity

Cancer chemotherapy and pharmacology, 2011-05, Vol.67 (5), p.1145-1155

2011

Volltextzugriff (PDF)

Disease progression and pharmacodynamics in parkinson disease - : Evidence for functional protection with levodopa and other treatments

Journal of pharmacokinetics and pharmacodynamics, 2006-06, Vol.33 (3), p.281-311

2006

Volltextzugriff (PDF)

Limited predictability of amikacin clearance in extreme premature neonates at birth

British journal of clinical pharmacology, 2006-01, Vol.61 (1), p.39-48

2006

Volltextzugriff (PDF)

Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics

Journal of pharmacokinetics and pharmacodynamics, 2014-02, Vol.41 (1), p.15-33

2014

Volltextzugriff (PDF)

Levodopa slows progression of parkinson's disease. external validation by clinical trial simulation

Pharmaceutical research, 2007-04, Vol.24 (4), p.791-802

2007

Volltextzugriff (PDF)

Population clinical pharmacology of children : modelling covariate effects

European journal of pediatrics, 2006-12, Vol.165 (12), p.819-829

2006

Volltextzugriff (PDF)

The Effect of Size, Maturation, Global Asphyxia, Cerebral Ischemia, and Therapeutic Hypothermia on the Pharmacokinetics of High-Dose Recombinant Erythropoietin in Fetal Sheep

International journal of molecular sciences, 2020-04, Vol.21 (9), p.3042

2020

Volltextzugriff (PDF)

Population pharmacokinetic and pharmacodynamic modelling of the effects of nicorandil in the treatment of acute heart failure

British journal of clinical pharmacology, 2008-09, Vol.66 (3), p.352-365

2008

Volltextzugriff (PDF)

Population clinical pharmacology of children : general principles

European journal of pediatrics, 2006-11, Vol.165 (11), p.741-746

2006

Volltextzugriff (PDF)

Simulation of correlated continuous and categorical variables using a single multivariate distribution

Journal of pharmacokinetics and pharmacodynamics, 2006-12, Vol.33 (6), p.773-794

2006

Volltextzugriff (PDF)

Does saturable formation of gemcitabine triphosphate occur in patients?

Cancer chemotherapy and pharmacology, 2008-12, Vol.63 (1), p.55-64

2008

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacodynamics of linezolid‐induced thrombocytopenia in hospitalized patients

British journal of clinical pharmacology, 2017-08, Vol.83 (8), p.1758-1772

2017

Volltextzugriff (PDF)

Nonlinear pharmacokinetics of piperacillin in healthy volunteers – implications for optimal dosage regimens

British journal of clinical pharmacology, 2010-11, Vol.70 (5), p.682-693

2010

Volltextzugriff (PDF)

Paracetamol and metabolite pharmacokinetics in infants

European journal of clinical pharmacology, 2003-07, Vol.59 (3), p.243-251

2003

Volltextzugriff (PDF)

Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis

Thorax, 2019-08, Vol.74 (8), p.740

2019

Volltextzugriff (PDF)

Erratum to: Does saturable formation of gemcitabine triphosphate occur in patients?

Cancer chemotherapy and pharmacology, 2015-03, Vol.75 (3), p.657-657

2015

Volltextzugriff (PDF)

A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children

British journal of clinical pharmacology, 2000-08, Vol.50 (2), p.125-134

2000

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic changes during the first four years of levodopa treatment in Parkinson's disease

Journal of pharmacokinetics and pharmacodynamics, 2005-08, Vol.32 (3-4), p.459-484

2005

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(95)
Reviews
(2)

Sprache

Englisch
(97)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Progression of motor and nonmotor features of Parkinson's disease and their response to treatment

SLCO1B1 rs4149032 Polymorphism Is Highly Prevalent in South Africans and Is Associated with Reduced Rifampin Concentrations: Dosing Implications

The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis

Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance

Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease

Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization

The population pharmacokinetics of allopurinol and oxypurinol in patients with gout

A combined pharmacokinetic model for the hypoxia-targeted prodrug PR-104A in humans, dogs, rats and mice predicts species differences in clearance and toxicity

Disease progression and pharmacodynamics in parkinson disease - : Evidence for functional protection with levodopa and other treatments

Limited predictability of amikacin clearance in extreme premature neonates at birth

Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics

Levodopa slows progression of parkinson's disease. external validation by clinical trial simulation

Population clinical pharmacology of children : modelling covariate effects

The Effect of Size, Maturation, Global Asphyxia, Cerebral Ischemia, and Therapeutic Hypothermia on the Pharmacokinetics of High-Dose Recombinant Erythropoietin in Fetal Sheep

Population pharmacokinetic and pharmacodynamic modelling of the effects of nicorandil in the treatment of acute heart failure

Population clinical pharmacology of children : general principles

Simulation of correlated continuous and categorical variables using a single multivariate distribution

Does saturable formation of gemcitabine triphosphate occur in patients?

Population pharmacokinetics and pharmacodynamics of linezolid‐induced thrombocytopenia in hospitalized patients

Nonlinear pharmacokinetics of piperacillin in healthy volunteers – implications for optimal dosage regimens

Paracetamol and metabolite pharmacokinetics in infants

Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis

Erratum to: Does saturable formation of gemcitabine triphosphate occur in patients?

A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children

Pharmacokinetic and pharmacodynamic changes during the first four years of levodopa treatment in Parkinson's disease

Suchergebnisse filtern